ID   FOXA1_RAT               Reviewed;         466 AA.
AC   P23512;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1991, sequence version 1.
DT   24-JUL-2024, entry version 171.
DE   RecName: Full=Hepatocyte nuclear factor 3-alpha;
DE            Short=HNF-3-alpha;
DE            Short=HNF-3A;
DE   AltName: Full=Forkhead box protein A1;
GN   Name=Foxa1; Synonyms=Hnf3a, Tcf-3a, Tcf3a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 313-337 AND 413-434.
RC   TISSUE=Liver;
RX   PubMed=2227418; DOI=10.1101/gad.4.8.1427;
RA   Lai E., Prezioso V.R., Smith E., Litvin O., Costa R.H., Darnell J.E. Jr.;
RT   "HNF-3A, a hepatocyte-enriched transcription factor of novel structure is
RT   regulated transcriptionally.";
RL   Genes Dev. 4:1427-1436(1990).
RN   [2]
RP   FUNCTION IN PROSTATE AR ACTIVATION, AND INTERACTION WITH AR.
RX   PubMed=12750453; DOI=10.1210/me.2003-0020;
RA   Gao N., Zhang J., Rao M.A., Case T.C., Mirosevich J., Wang Y., Jin R.,
RA   Gupta A., Rennie P.S., Matusik R.J.;
RT   "The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and
RT   androgen receptor in transcriptional regulation of prostatic genes.";
RL   Mol. Endocrinol. 17:1484-1507(2003).
RN   [3]
RP   FUNCTION, AND INTERACTION WITH NR0B2.
RX   PubMed=15358835; DOI=10.1210/me.2004-0211;
RA   Kim J.Y., Kim H.J., Kim K.T., Park Y.Y., Seong H.A., Park K.C., Lee I.K.,
RA   Ha H., Shong M., Park S.C., Choi H.S.;
RT   "Orphan nuclear receptor small heterodimer partner represses hepatocyte
RT   nuclear factor 3/Foxa transactivation via inhibition of its DNA binding.";
RL   Mol. Endocrinol. 18:2880-2894(2004).
RN   [4]
RP   DNA-BINDING, AND SUBUNIT.
RX   PubMed=17189638; DOI=10.1016/j.jmb.2006.11.087;
RA   Cirillo L.A., Zaret K.S.;
RT   "Specific interactions of the wing domains of FOXA1 transcription factor
RT   with DNA.";
RL   J. Mol. Biol. 366:720-724(2007).
RN   [5]
RP   FUNCTION, AND INTERACTION WITH NKX2-1.
RX   PubMed=17220277; DOI=10.1128/mcb.01133-06;
RA   Minoo P., Hu L., Xing Y., Zhu N.L., Chen H., Li M., Borok Z., Li C.;
RT   "Physical and functional interactions between homeodomain NKX2.1 and winged
RT   helix/forkhead FOXA1 in lung epithelial cells.";
RL   Mol. Cell. Biol. 27:2155-2165(2007).
RN   [6]
RP   FUNCTION IN PROSTATE AR ACTIVATION, AND INTERACTION WITH AR.
RX   PubMed=18178153; DOI=10.1016/j.bbrc.2007.12.162;
RA   Lee H.J., Hwang M., Chattopadhyay S., Choi H.S., Lee K.;
RT   "Hepatocyte nuclear factor-3 alpha (HNF-3alpha) negatively regulates
RT   androgen receptor transactivation in prostate cancer cells.";
RL   Biochem. Biophys. Res. Commun. 367:481-486(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-303, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Transcription factor that is involved in embryonic
CC       development, establishment of tissue-specific gene expression and
CC       regulation of gene expression in differentiated tissues. Is thought to
CC       act as a 'pioneer' factor opening the compacted chromatin for other
CC       proteins through interactions with nucleosomal core histones and
CC       thereby replacing linker histones at target enhancer and/or promoter
CC       sites. Binds DNA with the consensus sequence 5'-
CC       [AC]A[AT]T[AG]TT[GT][AG][CT]T[CT]-3'. Proposed to play a role in
CC       translating the epigenetic signatures into cell type-specific enhancer-
CC       driven transcriptional programs. Involved in glucose homeostasis;
CC       activates the GCG promoter. Involved in the development of multiple
CC       endoderm-derived organ systems such as the liver, pancreas, lungs and
CC       prostate; FOXA1 and FOXA2 seem to have at least in part redundant
CC       roles. Modulates the transcriptional activity of nuclear hormone
CC       receptors. Is required for maximal gene activation mediated by AR in
CC       the prostate. Negatively regulates AR transactivation via competition
CC       with coactivators such as NCOA2. Is involved in ESR1-mediated
CC       transcription. Involved in regulation of apoptosis. Involved in cell
CC       cycle regulation. Originally described as a transcription activator for
CC       a number of liver genes such as AFP, albumin, tyrosine
CC       aminotransferase, PEPCK, etc. Interacts with the cis-acting regulatory
CC       regions of these genes. {ECO:0000269|PubMed:12750453,
CC       ECO:0000269|PubMed:15358835, ECO:0000269|PubMed:17220277,
CC       ECO:0000269|PubMed:18178153}.
CC   -!- SUBUNIT: Binds DNA as a monomer. Interacts with FOXA2. Interacts with
CC       NKX2-1. Interacts with HDAC7. Interacts with the histone H3-H4
CC       heterodimer. Associates with nucleosomes containing histone H2A (By
CC       similarity). Interacts with AR. Interacts with NR0B2. {ECO:0000250,
CC       ECO:0000269|PubMed:12750453, ECO:0000269|PubMed:15358835,
CC       ECO:0000269|PubMed:17189638, ECO:0000269|PubMed:17220277,
CC       ECO:0000269|PubMed:18178153}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Liver.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X55955; CAA39418.1; -; mRNA.
DR   PIR; A36674; A36674.
DR   RefSeq; NP_036874.1; NM_012742.1.
DR   AlphaFoldDB; P23512; -.
DR   SMR; P23512; -.
DR   IntAct; P23512; 1.
DR   STRING; 10116.ENSRNOP00000009940; -.
DR   iPTMnet; P23512; -.
DR   PhosphoSitePlus; P23512; -.
DR   PaxDb; 10116-ENSRNOP00000009940; -.
DR   GeneID; 25098; -.
DR   KEGG; rno:25098; -.
DR   UCSC; RGD:2807; rat.
DR   AGR; RGD:2807; -.
DR   CTD; 3169; -.
DR   RGD; 2807; Foxa1.
DR   eggNOG; KOG3563; Eukaryota.
DR   InParanoid; P23512; -.
DR   OrthoDB; 5385885at2759; -.
DR   Reactome; R-RNO-9018519; Estrogen-dependent gene expression.
DR   PRO; PR:P23512; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005902; C:microvillus; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:BHF-UCL.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:MGI.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IDA:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; IPI:ARUK-UCL.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0061144; P:alveolar secondary septum development; ISO:RGD.
DR   GO; GO:0048646; P:anatomical structure formation involved in morphogenesis; ISO:RGD.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0006338; P:chromatin remodeling; ISO:RGD.
DR   GO; GO:0061448; P:connective tissue development; ISO:RGD.
DR   GO; GO:0071542; P:dopaminergic neuron differentiation; ISO:RGD.
DR   GO; GO:0021904; P:dorsal/ventral neural tube patterning; ISO:RGD.
DR   GO; GO:0060743; P:epithelial cell maturation involved in prostate gland development; ISO:RGD.
DR   GO; GO:0060441; P:epithelial tube branching involved in lung morphogenesis; ISO:RGD.
DR   GO; GO:0042593; P:glucose homeostasis; ISO:RGD.
DR   GO; GO:0042445; P:hormone metabolic process; ISO:RGD.
DR   GO; GO:0030324; P:lung development; ISO:RGD.
DR   GO; GO:0060487; P:lung epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0060425; P:lung morphogenesis; ISO:RGD.
DR   GO; GO:0060739; P:mesenchymal-epithelial cell signaling involved in prostate gland development; ISO:RGD.
DR   GO; GO:0010719; P:negative regulation of epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IGI:MGI.
DR   GO; GO:0030182; P:neuron differentiation; ISO:RGD.
DR   GO; GO:0048665; P:neuron fate specification; ISO:RGD.
DR   GO; GO:0007219; P:Notch signaling pathway; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:RGD.
DR   GO; GO:1904340; P:positive regulation of dopaminergic neuron differentiation; ISO:RGD.
DR   GO; GO:1901300; P:positive regulation of hydrogen peroxide-mediated programmed cell death; IMP:RGD.
DR   GO; GO:0033148; P:positive regulation of intracellular estrogen receptor signaling pathway; ISO:RGD.
DR   GO; GO:0045931; P:positive regulation of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0045880; P:positive regulation of smoothened signaling pathway; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:0060740; P:prostate gland epithelium morphogenesis; ISO:RGD.
DR   GO; GO:0060741; P:prostate gland stromal morphogenesis; ISO:RGD.
DR   GO; GO:0051726; P:regulation of cell cycle; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:1902691; P:respiratory basal cell differentiation; ISO:RGD.
DR   GO; GO:0032355; P:response to estradiol; ISO:RGD.
DR   GO; GO:0060528; P:secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development; ISO:RGD.
DR   GO; GO:0007224; P:smoothened signaling pathway; ISO:RGD.
DR   GO; GO:0035239; P:tube morphogenesis; ISO:RGD.
DR   CDD; cd20038; FH_FOXA1; 1.
DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1.
DR   InterPro; IPR013638; Fork-head_N.
DR   InterPro; IPR001766; Fork_head_dom.
DR   InterPro; IPR018533; Forkhead_box_C.
DR   InterPro; IPR050211; FOX_domain-containing.
DR   InterPro; IPR018122; TF_fork_head_CS_1.
DR   InterPro; IPR030456; TF_fork_head_CS_2.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR11829; FORKHEAD BOX PROTEIN; 1.
DR   PANTHER; PTHR11829:SF195; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; 1.
DR   Pfam; PF00250; Forkhead; 1.
DR   Pfam; PF08430; Forkhead_N; 1.
DR   Pfam; PF09354; HNF_C; 1.
DR   PRINTS; PR00053; FORKHEAD.
DR   SMART; SM00339; FH; 1.
DR   SUPFAM; SSF46785; Winged helix' DNA-binding domain; 1.
DR   PROSITE; PS00657; FORK_HEAD_1; 1.
DR   PROSITE; PS00658; FORK_HEAD_2; 1.
DR   PROSITE; PS50039; FORK_HEAD_3; 1.
PE   1: Evidence at protein level;
KW   Activator; Chromatin regulator; Developmental protein;
KW   Direct protein sequencing; DNA-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repressor; Transcription; Transcription regulation.
FT   CHAIN           1..466
FT                   /note="Hepatocyte nuclear factor 3-alpha"
FT                   /id="PRO_0000091794"
FT   DNA_BIND        169..260
FT                   /note="Fork-head"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00089"
FT   REGION          251..288
FT                   /note="Essential for DNA binding"
FT   REGION          269..358
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        330..357
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         303
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         327
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P55317"
SQ   SEQUENCE   466 AA;  48775 MW;  06555BA74BD9B7DC CRC64;
     MLGTVKMEGH ESNDWNSYYA DTQEAYSSVP VSNMNSGLGS MNSMNTYMTM NTMTTSGNMT
     PASFNMSYAN PGLGAGLSPG AVAGMPGGSA GAMNSMTAAG VTAMGAALSP GGMGSMGAQP
     AASMNGLGPY AAAMNPCMSP MAYAPSNLGR SRAGGGGDAK TFKRSYPHAK PPYSYISLIT
     MAIQQAPSKM LTLSEIYQWI MDLFPYYRQN QQRWQNSIRH SLSFNACFVK VARSPDKPGK
     GSYWTLHPDS GNMFENGCYL RRQKRFKCEK QPGAGGGSGG GGSKGVPENR KDPSGPVNPS
     AESPIHRGVH GKASQLEGAP APGPAASPQT LDHSGATATG GGSELKSPAS SSAPPISSGP
     GGWICTPLSP TWLAPHESQL HLKGAPHYSF NHPFSINNLM SSSEQQHKLD FKAYEQALQY
     SPYGATLPAS LPLGGASVAT RSPIEPSALE PAYYQGVYSR PVLNTS
//
